부산대학교 도서관

The use of hospital glucose meters is widely established; however, the reliability of glucose meters can vary according to the type of patient group tested. Significant error rates can occur with point-of-care glucose level measurements owing to hematocrit effect and/or chemical interferences associated with drug therapy and patient treatment protocols. In addition, chemical interference with some current glucose meters because of dialysate composition has been observed in patients with renal disease undergoing peritoneal dialysis. The new generation StatStrip glucose meter (Nova Biomedical, Waltham, Mass) has been designed to compensate for interference effects commonly associated with other currently available glucose meters. A previous laboratory evaluation of StatStrip in our hands demonstrated good precision and correlation to the central laboratory hexokinase reference method. The aims of this study were to assess the response of StatStrip to analytical interferences likely to be encountered in hospitalized patients and to evaluate the reliability of StatStrip for application to patients attending a specialized dialysis care center.